11th Circ. Won't Revive Investor Suit Against Med Tech Co.
The Eleventh Circuit on Monday affirmed the toss of a proposed securities class action against Axogen Inc. in the wake of a short-seller report that found the medical technology company overstated...To view the full article, register now.
Already a subscriber? Click here to view full article